Therapeutic strategies to slow chronic kidney disease progression. - Wikidata - awgldk - TriplyDB

Therapeutic strategies to slow chronic kidney disease progression.

Therapeutic strategies to slow chronic kidney disease progression.

http://www.wikidata.org/entity/Q36510669

about

Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.Risk factors for progression of chronic kidney disease.Clinical utility of valsartan in the treatment of hypertension in children and adolescents Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.Association between common iron store markers and hemoglobin in children with chronic kidney disease.Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome The growth factor midkine regulates the renin-angiotensin system in mice Feline CKD: New horizons - where do we go from here?Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.Treatment strategies to prevent renal damage in hypertensive children.Survival in children requiring chronic renal replacement therapy.Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study.Is Blood Pressure Improving in Children With Chronic Kidney Disease? A Period Analysis.Steroid-resistant nephrotic syndrome: past and current perspectives.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.Development of tandem mass spectrometry-based creatinine measurement using dried blood spot for newborn mass screening.

P2860

Q33404886-1BF02177-50CF-439D-AD9A-A28486F5B8A4 Q34169794-2C1E58F2-9997-46B4-8272-D729E41233FE Q34957546-98416B83-8C90-467A-B9F4-01A192814C03 Q35895028-C6209658-26B5-4540-8338-26ABE459D87A Q36381297-6AE8D6F9-3EA3-4F76-A447-9396C42E0700 Q37195386-9C6526DC-1A63-4AC2-94CA-06111F6D57EE Q37209205-249F318C-5A29-492F-A15A-C85BA07F06C3 Q38133700-E267E39E-A6D1-480A-B309-8746B1081805 Q38134288-C562F0E8-0548-491A-9FF9-7619E4F4937D Q38187597-3613DA1F-AAEF-4AA1-81F2-A2856860EC5D Q38784291-52315002-5618-4F6A-92C5-7345315391FC Q45812644-0368B123-997A-4687-9D7B-4A615F597057 Q47218022-965DC5F8-2B56-48A8-97FF-B529D968A940 Q49500608-E0FD6264-9600-4B3C-8AAE-332C14607332 Q50063239-D6C7F2F7-E91D-478F-9A1F-A44CED5FB562 Q50210234-DEB15242-5B9C-4863-A9F6-A5FC04287A6E

P2860

Therapeutic strategies to slow chronic kidney disease progression.

http://www.wikidata.org/entity/Q36510669

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Therapeutic strategies to slow chronic kidney disease progression.

@ast

Therapeutic strategies to slow chronic kidney disease progression.

@en

type

label

Therapeutic strategies to slow chronic kidney disease progression.

@ast

Therapeutic strategies to slow chronic kidney disease progression.

@en

prefLabel

Therapeutic strategies to slow chronic kidney disease progression.

@ast

Therapeutic strategies to slow chronic kidney disease progression.

@en

P1433

Q36510669-E4FD523E-9B31-4F4D-8F76-302FD9ACBAED

P1476

Q36510669-211310A0-5CAD-484D-BA16-72330EA5D778

P2093

Q36510669-E6ECC8A5-7FD9-46A1-83CD-48822EFFE764

Q36510669-F05882BE-6C4F-435F-A806-894DF8BEDFDF

P275

Q36510669-A36448A8-70EA-405B-8298-D0790482089B

P2860

Q36510669-043B1FD3-87C8-4C57-A3BE-D1EAF80D2B4E

Q36510669-069F8AA8-6582-44C9-B7A2-C2160428D406

Q36510669-0AE1A43D-92A3-4069-9AD6-ACAFD9FBAF98

Q36510669-0B0C1F66-2B10-473B-A706-9A48C557F557

Q36510669-169BF6A5-C2EB-4E3D-9571-12BE554ACC4F

Q36510669-1C0928F1-BB80-41CE-95A5-5891C66A35F2

Q36510669-1C41CA1D-324A-424C-9E9C-1C26B280F2D0

Q36510669-1DFE5D8A-1167-4877-BB62-21EC6AED90EC

Q36510669-1E6ECA49-8109-4CC5-9FA8-618C62530BC6

Q36510669-1FD1ADCF-9552-4325-B279-0EA40AF4EE2F

P2888

Q36510669-403383A4-9CD8-4054-A625-9B62D8666AAC

P304

Q36510669-813D6A35-7AED-42BC-85BA-846232B2DC6A

P31

Q36510669-48BDF44A-9836-4FBC-B691-CCC05590BFDE

Q36510669-5725584E-5788-4DFF-96B1-41A747F9419D

P356

Q36510669-CE9C276D-0C0E-4AA9-B44D-9144BA2C42CE

P433

Q36510669-88C3AB05-5A49-4C7A-B323-371C4CC68D36

P478

Q36510669-E7ECC955-ECC3-4159-B6E6-AA879C8F521E

P577

Q36510669-CBDADBEF-E610-4B1F-84B0-D2120FA9C492

Q36510669-E3B4E9A8-64BD-4DC5-AA34-81259C72F3EB

P5875

Q36510669-4345D155-5F84-4DB8-8E36-88E99DAA5098

P698

Q36510669-39E7142F-0DB2-4917-B56D-1370EB7D10D2

P921

Q36510669-0E9E6692-0193-4283-8C3B-38D600B9271B

Q36510669-43B45112-D00E-4F52-A343-2F209E34E5CA

Q36510669-4DEC4122-0187-4157-BA6A-2DFB80F14277

Q36510669-E58EBB8B-B5BE-4B4F-B33A-6D5D3227B17A

P932

Q36510669-CA74FEFF-07C3-459C-9322-9B8E35AF4631

P356

S00467-008-0789-Y

P1433

Pediatric Nephrology

P1476

Therapeutic strategies to slow chronic kidney disease progression.

@en

P2093

Elke Wühl

http://www.w3.org/2001/XMLSchema#string

Franz Schaefer

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

Protein restriction for children with chronic kidney disease

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Epidemiology of chronic renal failure in children: data from the ItalKid project.

Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

P2888

s00467-008-0789-y

P304

705-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-008-0789-Y

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5517562

http://www.w3.org/2001/XMLSchema#string

P698

18335252

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

arterial hypertension

chronic kidney disease

P932

2275772

http://www.w3.org/2001/XMLSchema#string